Literature DB >> 18456253

Memantine does not show intracellular block of the NMDA receptor channel.

Chris G Parsons1, Kate E Gilling, Claudia Jatzke.   

Abstract

Mg2+ is known to gain access to the NMDA receptor channel from both the extra- and intracellular compartments. Memantine, being an amphiphilic substance, reaches intracellular concentrations of approximately 30 microM, which are much higher than therapeutic extracellular concentrations ( approximately 1 microM). We therefore investigated whether memantine can also block the NMDA receptor channel from the intracellular compartment. NR1a/NR2A receptors were expressed in Xenopus oocytes and in classical two electrode voltage-clamp recordings, voltage-ramps from -100 to +100 mV confirmed moderate inward rectification of NR1a/NR2A receptor control responses at positive membrane potentials above +40 mV. Patch clamp recordings from these same cells (applying 100 microM glutamate and 1 mM Mg2+) revealed similar rectification at positive potentials in cell-attached mode which disappeared after pulling an inside-out patch. Application of 1 mM Mg2+ to the intracellular side of the receptor re-introduced the rectification seen in cell-attached mode, and 5 mM Mg2+ produced much more pronounced block. In contrast, 30 microM memantine was completely unable to block the NMDA receptor from the intracellular compartment. In conclusion, intracellular block of the NMDA receptor, as reported for Mg2+, is not of significance for the therapeutic effects of memantine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18456253     DOI: 10.1016/j.ejphar.2008.03.053

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons.

Authors:  Yuen-Shan Ho; Man-Shan Yu; Suet-Yi Yik; Kwok-Fai So; Wai-Hung Yuen; Raymond Chuen-Chung Chang
Journal:  Cell Mol Neurobiol       Date:  2009-12       Impact factor: 5.046

2.  Effects of Mg2+ on recovery of NMDA receptors from inhibition by memantine and ketamine reveal properties of a second site.

Authors:  Nathan G Glasgow; Madeleine R Wilcox; Jon W Johnson
Journal:  Neuropharmacology       Date:  2018-05-12       Impact factor: 5.250

3.  Effects of memantine on convulsive reactions and the organization of sleep in krushinskii-molodkina rats with an inherited predisposition to audiogenic convulsions.

Authors:  S I Vataev; E P Zhabko; N Ya Lukomskaya; G A Oganesyan; L G Magazanik
Journal:  Neurosci Behav Physiol       Date:  2010-08-04

4.  Functional architecture of olfactory ionotropic glutamate receptors.

Authors:  Liliane Abuin; Benoîte Bargeton; Maximilian H Ulbrich; Ehud Y Isacoff; Stephan Kellenberger; Richard Benton
Journal:  Neuron       Date:  2011-01-13       Impact factor: 17.173

5.  Inhibition of NMDA receptors through a membrane-to-channel path.

Authors:  Madeleine R Wilcox; Aparna Nigam; Nathan G Glasgow; Chamali Narangoda; Matthew B Phillips; Dhilon S Patel; Samaneh Mesbahi-Vasey; Andreea L Turcu; Santiago Vázquez; Maria G Kurnikova; Jon W Johnson
Journal:  Nat Commun       Date:  2022-07-15       Impact factor: 17.694

6.  Key binding interactions for memantine in the NMDA receptor.

Authors:  Walrati Limapichat; Wesley Y Yu; Emma Branigan; Henry A Lester; Dennis A Dougherty
Journal:  ACS Chem Neurosci       Date:  2012-12-07       Impact factor: 4.418

7.  Fast, non-competitive and reversible inhibition of NMDA-activated currents by 2-BFI confers neuroprotection.

Authors:  Zhao Han; Jin-Long Yang; Susan X Jiang; Sheng-Tao Hou; Rong-Yuan Zheng
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

Review 8.  Memantine for the Treatment of Dementia: A Review on its Current and Future Applications.

Authors:  Jaume Folch; Oriol Busquets; Miren Ettcheto; Elena Sánchez-López; Ruben Dario Castro-Torres; Ester Verdaguer; Maria Luisa Garcia; Jordi Olloquequi; Gemma Casadesús; Carlos Beas-Zarate; Carme Pelegri; Jordi Vilaplana; Carme Auladell; Antoni Camins
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.